185 related articles for article (PubMed ID: 29332580)
1. Aurora Kinase Inhibitors in Head and Neck Cancer.
Qi G; Liu J; Mi S; Tsunematsu T; Jin S; Shao W; Liu T; Ishimaru N; Tang B; Kudo Y
Curr Top Med Chem; 2018; 18(3):199-213. PubMed ID: 29332580
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a highly selective inhibitor of the Aurora kinases.
Ferguson FM; Doctor ZM; Chaikuad A; Sim T; Kim ND; Knapp S; Gray NS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4405-4408. PubMed ID: 28818446
[TBL] [Abstract][Full Text] [Related]
3. SAR156497, an exquisitely selective inhibitor of aurora kinases.
Carry JC; Clerc F; Minoux H; Schio L; Mauger J; Nair A; Parmantier E; Le Moigne R; Delorme C; Nicolas JP; Krick A; Abécassis PY; Crocq-Stuerga V; Pouzieux S; Delarbre L; Maignan S; Bertrand T; Bjergarde K; Ma N; Lachaud S; Guizani H; Lebel R; Doerflinger G; Monget S; Perron S; Gasse F; Angouillant-Boniface O; Filoche-Rommé B; Murer M; Gontier S; Prévost C; Monteiro ML; Combeau C
J Med Chem; 2015 Jan; 58(1):362-75. PubMed ID: 25369539
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinases in head and neck cancer.
Mehra R; Serebriiskii IG; Burtness B; Astsaturov I; Golemis EA
Lancet Oncol; 2013 Sep; 14(10):e425-35. PubMed ID: 23993387
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
Borisa AC; Bhatt HG
Eur J Med Chem; 2017 Nov; 140():1-19. PubMed ID: 28918096
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinases: novel therapy targets in cancers.
Tang A; Gao K; Chu L; Zhang R; Yang J; Zheng J
Oncotarget; 2017 Apr; 8(14):23937-23954. PubMed ID: 28147341
[TBL] [Abstract][Full Text] [Related]
7. 3-Cyano-6-(5-methyl-3-pyrazoloamino) pyridines (Part 2): A dual inhibitor of Aurora kinase and tubulin polymerization.
Morioka M
Bioorg Med Chem Lett; 2016 Dec; 26(24):5860-5862. PubMed ID: 27884697
[TBL] [Abstract][Full Text] [Related]
8. Aurora kinase inhibitors: a patent review (2014-2020).
Jing XL; Chen SW
Expert Opin Ther Pat; 2021 Jul; 31(7):625-644. PubMed ID: 33573401
[No Abstract] [Full Text] [Related]
9. Aurora kinase inhibitors as potential anticancer agents: Recent advances.
Pradhan T; Gupta O; Singh G; Monga V
Eur J Med Chem; 2021 Oct; 221():113495. PubMed ID: 34020340
[TBL] [Abstract][Full Text] [Related]
10. Multi-kinase inhibitors, AURKs and cancer.
Cicenas J; Cicenas E
Med Oncol; 2016 May; 33(5):43. PubMed ID: 27038473
[TBL] [Abstract][Full Text] [Related]
11. The Aurora kinase inhibitors in cancer research and therapy.
Cicenas J
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1995-2012. PubMed ID: 26932147
[TBL] [Abstract][Full Text] [Related]
12. Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors.
Sarvagalla S; Coumar MS
Curr Cancer Drug Targets; 2015; 15(5):375-93. PubMed ID: 25895501
[TBL] [Abstract][Full Text] [Related]
13. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).
Cheung CH; Sarvagalla S; Lee JY; Huang YC; Coumar MS
Expert Opin Ther Pat; 2014 Sep; 24(9):1021-38. PubMed ID: 24965505
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity to aurora kinase inhibitors in cells resistant against platinum- containing anticancer agents.
Akiyama M; Izumi H; Wang KY; Yamaguchi T; Kuma A; Kitamura N; Harada Y; Oya R; Yamaguchi K; Iwai Y; Kohno K
Anticancer Agents Med Chem; 2014; 14(7):1042-50. PubMed ID: 24521151
[TBL] [Abstract][Full Text] [Related]
16. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
17. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors.
Wang W; Feng X; Liu HX; Chen SW; Hui L
Bioorg Med Chem; 2018 Jul; 26(12):3217-3226. PubMed ID: 29705376
[TBL] [Abstract][Full Text] [Related]
19. Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM).
Yan A; Nie X; Wang K; Wang M
Eur J Med Chem; 2013 Mar; 61():73-83. PubMed ID: 22796044
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase inhibitors as anticancer molecules.
Katayama H; Sen S
Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
